Effects of exenatide (exendin-4) on glycemic control and weight over 30 weeks in metformin-treated patients with Type 2 diabetes

被引：0
|
作者：
DeFronzo, R
Ratner, R
Han, J
Kim, D
Fineman, M
Baron, A
机构：
[1] Univ Texas, Hlth Sci Ctr, Diabet Div, San Antonio, TX USA
[2] George Washington Univ, Sch Med, Dept Med, Bethesda, MD USA
[3] Amylin Pharmaceut Inc, Clin Affairs, San Diego, CA USA
来源：
DIABETOLOGIA | 2004年 / 47卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
775
引用
收藏
页码：A280 / A280
页数：1
相关论文
共 50 条
  • [41] Effects of exenatide on glycemic control, weight, lipid and blood pressure in 129 patients with type 2 diabetes: predictors of good response
    Lemaitre-Brame, L.
    Rouget, J. P.
    Delecourt, F.
    Jeanjean, M. E.
    Merlen, E.
    Vambergue, A.
    Fontaine, P.
    DIABETES & METABOLISM, 2012, 38 : A104 - A104
  • [42] Glycemic control and cardiovascular risk profile in patients with type 2 diabetes treated with repaglinide or metformin
    Mugellini, A
    Derosa, G
    Ciccarelli, L
    Fogari, R
    DIABETES, 2002, 51 : A500 - A500
  • [43] Metabolic control and weight loss in patients with obesity and type 2 diabetes mellitus, treated with exenatide
    Pujante Alarcon, Pedro
    Hellin Gil, Maria Dolores
    Miguel Roman, Luis
    Ferrer Gomez, Mercedes
    Garcia Zafra, Maria Victoria
    Tebar Masso, Javier
    MEDICINA CLINICA, 2012, 139 (13): : 572 - 578
  • [44] Effects of Exenatide Compared to Glibenclamide on Glycemic Control and on Insulin Resistance in Type 2 Diabetic Patients with Metformin Therapy
    Derosa, Giuseppe
    Ragonesi, Pietro D.
    Salvadeo, Sibilla A. T.
    Ferrari, Ilaria
    Querci, Fabrizio
    Franzetti, Ivano G.
    Gadaleta, Gennaro
    Ciccarelli, Leonardina
    Piccinni, Mario N.
    D'Angelo, Angela
    Cicero, Arrigo F. G.
    DIABETES, 2009, 58 : A133 - A133
  • [45] Improved glycemic control and reductions in body weight in exenatide-treated subjects with type 2 diabetes with modest hyperglycemia
    Wintle, M
    Kim, D
    Poon, T
    Shen, LZ
    Mac, S
    Nelson, P
    DIABETOLOGIA, 2005, 48 : A288 - A288
  • [46] Addition of sitagliptin to ongoing metformin monotherapy improves glycemic control in Japanese patients with type 2 diabetes over 52weeks
    Kadowaki, Takashi
    Tajima, Naoko
    Odawara, Masato
    Nishii, Mikio
    Taniguchi, Tadaaki
    Ferreira, Juan Camilo Arjona
    JOURNAL OF DIABETES INVESTIGATION, 2013, 4 (02) : 174 - 181
  • [47] Randomized Trial of Continuous Subcutaneous Delivery of Exenatide by ITCA 650 Versus Twice-Daily Exenatide Injections in Metformin-Treated Type 2 Diabetes
    Henry, Robert R.
    Rosenstock, Julio
    Logan, Douglas K.
    Alessi, Thomas R.
    Luskey, Kenneth
    Baron, Michelle A.
    DIABETES CARE, 2013, 36 (09) : 2559 - 2565
  • [48] Impact of Baseline BMI on Glycemic Control and Weight Change with Exenatide Monotherapy in Chinese Type 2 Diabetes Patients
    Deng, Hongrong
    Lin, Shuo
    Lv, Jing
    Xu, Wen
    Luo, Sihui
    Yao, Bin
    Weng, Jianping
    DIABETES, 2016, 65 : A572 - A573
  • [49] Exenatide improves postprandial hyperglycemia and dyslipidemia in metformin treated patients with type 2 diabetes
    Bunck, Mathijs C.
    Corner, Anja
    Diamant, Michaela
    Eliasson, Bjorn
    Malloy, Jaret L.
    Shaginian, Rimma M.
    Ding, Wei
    Kendall, David M.
    Smith, Ulf
    Yki-Jarvinen, Hannele
    Heine, Robert J.
    Taskinen, Marja-Ritta
    DIABETES, 2008, 57 : A33 - A33
  • [50] Exenatide improves postprandial hyperglycaemia and dyslipidaemia in metformin treated patients with type 2 diabetes
    Bunck, M. C.
    Corner, A.
    Diamant, M.
    Eliasson, B.
    Malloy, J. L.
    Shaginian, R. M.
    Deng, W.
    Kendall, D. M.
    Smith, U.
    Yki-Jarvinen, H.
    Heine, R. J.
    Taskinen, M. R.
    DIABETOLOGIA, 2008, 51 : S351 - S351
12345